Millennium Management’s SALIX PHARMACEUTICALS LTD DEL SLXP Stock Holding History

Millennium Management’s Portfolio SLXP Stock Details SLXP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-838,953	Closed	-$145M	–	4239
2015 Q1	$145M	Buy	838,953 +327,770	+64%	+$48.1M	0.27%	54
2014 Q4	$58.8M	Sell	511,183 -206,951	-29%	-$25.1M	0.12%	180
2014 Q3	$112M	Buy	718,134 +85,352	+13%	+$12.4M	0.28%	42
2014 Q2	$78.1M	Buy	632,782 +244,019	+63%	+$27M	0.22%	76
2014 Q1	$40.3M	Sell	388,763 -73,058	-16%	-$7.48M	0.12%	198
2013 Q4	$41.5M	Buy	461,821 +251,990	+120%	+$20.1M	0.13%	142
2013 Q3	$14M	Sell	209,831 -88,610	-30%	-$6.11M	0.05%	527
2013 Q2	$19.7M	Buy	+298,441	New	+$17.1M	0.06%	322

Other funds holding SLXP

MMG

Monetary Management Group St Louis, Missouri $419M AUM 29.55% 1-Year Est. Return

Millennium Management's SLXP Position: Q2 2015 in Review

Millennium Management sold out of SALIX PHARMACEUTICALS LTD DEL (SLXP) in Q2 2015, closing a stake of 838,953 shares — an estimated $145M sold.

Millennium Management first reported a position in SLXP in Q2 2013 and held it in 8 quarters. The position peaked at $145M in Q1 2015. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

Millennium Management reported no remaining SALIX PHARMACEUTICALS LTD DEL position as of Q2 2015 after selling out during the quarter.
Millennium Management sold 838,953 SALIX PHARMACEUTICALS LTD DEL shares in Q2 2015, an estimated $145M.
Millennium Management first reported a position in SALIX PHARMACEUTICALS LTD DEL in Q2 2013 and held it in 8 quarters.
Millennium Management's SALIX PHARMACEUTICALS LTD DEL position peaked at $145M in Q1 2015.
1 fund tracked by Wall St. Rank held SALIX PHARMACEUTICALS LTD DEL as of Q2 2015.

Based on Millennium Management's 13F filing for Q2 2015, filed 14 Aug 2015.